194 related articles for article (PubMed ID: 1754810)
1. Anti-dsDNA: choice of assay in relation to clinical value.
Smeenk RJ; van den Brink HG; Brinkman K; Termaat RM; Berden JH; Swaak AJ
Rheumatol Int; 1991; 11(3):101-7. PubMed ID: 1754810
[TBL] [Abstract][Full Text] [Related]
2. Detection of antibodies to DNA: a technical assessment.
Smeenk R; Hylkema M
Mol Biol Rep; 1992 Nov; 17(1):71-9. PubMed ID: 1287479
[TBL] [Abstract][Full Text] [Related]
3. The clinical significance of measuring different anti-dsDNA antibodies by using the Farr assay, an enzyme immunoassay and a Crithidia luciliae immunofluorescence test.
Werle E; Blazek M; Fiehn W
Lupus; 1992 Dec; 1(6):369-77. PubMed ID: 1304405
[TBL] [Abstract][Full Text] [Related]
4. [Detection of dsDNA antibodies in diagnosis of systemic lupus erythematosus--comparative studies of diagnostic effectiveness of 3 ELISA methods with different antigens and a Crithidia luciliae immunofluorescence test].
Wigand R; Gottschalk R; Falkenbach A; Matthias T; Kaltwasser JP; Hoelzer D
Z Rheumatol; 1997; 56(2):53-62. PubMed ID: 9235810
[TBL] [Abstract][Full Text] [Related]
5. Anti-dsDNA antibodies and disease classification in antinuclear antibody positive patients: the role of analytical diversity.
Haugbro K; Nossent JC; Winkler T; Figenschau Y; Rekvig OP
Ann Rheum Dis; 2004 Apr; 63(4):386-94. PubMed ID: 15020332
[TBL] [Abstract][Full Text] [Related]
6. Clinical significance of anti-nDNA antibodies in ANA-positive systemic lupus erythematosus: comparison of the Farr radioimmunoassay and the Crithidia luciliae immunofluorescent technique.
Chuan MT; Wu YC; Ang ET; Wang JH; In KL; Lü YC
Zhonghua Min Guo Wei Sheng Wu Ji Mian Yi Xue Za Zhi; 1985 Feb; 18(1):15-24. PubMed ID: 3896689
[TBL] [Abstract][Full Text] [Related]
7. Dissociation studies of DNA/anti-DNA complexes in relation to anti-DNA avidity.
Smeenk RJ; Van Rooijen A; Swaak TJ
J Immunol Methods; 1988 Apr; 109(1):27-35. PubMed ID: 3282012
[TBL] [Abstract][Full Text] [Related]
8. Measurement of increases in anti-double-stranded DNA antibody levels as a predictor of disease exacerbation in systemic lupus erythematosus. A long-term, prospective study.
ter Borg EJ; Horst G; Hummel EJ; Limburg PC; Kallenberg CG
Arthritis Rheum; 1990 May; 33(5):634-43. PubMed ID: 2346519
[TBL] [Abstract][Full Text] [Related]
9. [Determination of anti dsDNA antibodies by immunofluorescence using Crithidia luciliae. I--Diagnostic and prognostic value in systemic lupus erythematosus. Comparison with the Farr radioimmunoassay].
Borda-Iriarte O; Meyer O; Cyna J; Haïm T; Ryckewaert A
Rev Rhum Mal Osteoartic; 1984 Apr; 51(4):185-91. PubMed ID: 6374861
[TBL] [Abstract][Full Text] [Related]
10. Detection of anti-dsDNA as a diagnostic tool: a prospective study in 441 non-systemic lupus erythematosus patients with anti-dsDNA antibody (anti-dsDNA).
Swaak T; Smeenk R
Ann Rheum Dis; 1985 Apr; 44(4):245-51. PubMed ID: 3872637
[TBL] [Abstract][Full Text] [Related]
11. Diagnosing systemic lupus erythematosus: new-generation immunoassays for measurement of anti-dsDNA antibodies are an effective alternative to the Farr technique and the Crithidia luciliae immunofluorescence test.
Antico A; Platzgummer S; Bassetti D; Bizzaro N; Tozzoli R; Villalta D;
Lupus; 2010 Jul; 19(8):906-12. PubMed ID: 20179169
[TBL] [Abstract][Full Text] [Related]
12. Low avidity antibodies to dsDNA as a diagnostic tool.
Nossent JC; Huysen V; Smeenk RJ; Swaak AJ
Ann Rheum Dis; 1989 Sep; 48(9):748-52. PubMed ID: 2802796
[TBL] [Abstract][Full Text] [Related]
13. Detection of anti-dsDNA as diagnostic tool.
Swaak AJ; Groenwold J; Aarden LA; Feltkamp TE
Ann Rheum Dis; 1981 Feb; 40(1):45-9. PubMed ID: 7008712
[TBL] [Abstract][Full Text] [Related]
14. Low avidity antibodies to double stranded DNA in systemic lupus erythematosus: a longitudinal study of their clinical significance.
Nossent JC; Huysen V; Smeenk RJ; Swaak AJ
Ann Rheum Dis; 1989 Aug; 48(8):677-82. PubMed ID: 2789501
[TBL] [Abstract][Full Text] [Related]
15. BioPlex 2200 multiplexed system: simultaneous detection of anti-dsDNA and anti-chromatin antibodies in patients with systemic lupus erythematosus.
Bardin N; Desplat-Jego S; Daniel L; Jourde Chiche N; Sanmarco M
Autoimmunity; 2009 Jan; 42(1):63-8. PubMed ID: 19127456
[TBL] [Abstract][Full Text] [Related]
16. The significance of discrepant Farr and Crithidia luciliae tests.
McGuigan L; Edmonds J; Wellings G; Jones M
J Rheumatol; 1984 Apr; 11(2):172-4. PubMed ID: 6610050
[TBL] [Abstract][Full Text] [Related]
17. A novel DNA/histone H4 peptide complex detects autoantibodies in systemic lupus erythematosus sera.
Panza F; Alcaro MC; Petrelli F; Angelotti F; Pratesi F; Rovero P; Migliorini P
Arthritis Res Ther; 2016 Oct; 18(1):220. PubMed ID: 27716380
[TBL] [Abstract][Full Text] [Related]
18. Measurement of low avidity anti-dsDNA by the Crithidia luciliae test and the PEG assay.
Smeenk R; van der Lelij G; Aarden L
Clin Exp Immunol; 1982 Sep; 49(3):603-10. PubMed ID: 6756723
[TBL] [Abstract][Full Text] [Related]
19. Anti-DNA antibodies: a diagnostic and prognostic tool for systemic lupus erythematosus?
Riboldi P; Gerosa M; Moroni G; Radice A; Allegri F; Sinico A; Tincani A; Meroni PL
Autoimmunity; 2005 Feb; 38(1):39-45. PubMed ID: 15804704
[TBL] [Abstract][Full Text] [Related]
20. Clinical significance of ELISA positive and immunofluorescence negative anti-dsDNA antibody.
Kim KH; Han JY; Kim JM; Lee SW; Chung WT
Clin Chim Acta; 2007 May; 380(1-2):182-5. PubMed ID: 17355877
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
